JP2008540540A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540540A5
JP2008540540A5 JP2008511233A JP2008511233A JP2008540540A5 JP 2008540540 A5 JP2008540540 A5 JP 2008540540A5 JP 2008511233 A JP2008511233 A JP 2008511233A JP 2008511233 A JP2008511233 A JP 2008511233A JP 2008540540 A5 JP2008540540 A5 JP 2008540540A5
Authority
JP
Japan
Prior art keywords
therapeutic compound
mixture
pharmaceutical composition
extruder
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511233A
Other languages
English (en)
Japanese (ja)
Other versions
JP5400377B2 (ja
JP2008540540A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/017708 external-priority patent/WO2006122021A1/en
Publication of JP2008540540A publication Critical patent/JP2008540540A/ja
Publication of JP2008540540A5 publication Critical patent/JP2008540540A5/ja
Application granted granted Critical
Publication of JP5400377B2 publication Critical patent/JP5400377B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008511233A 2005-05-10 2006-05-08 圧縮性に乏しい治療用化合物を有する組成物の製造法 Expired - Fee Related JP5400377B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US67958705P 2005-05-10 2005-05-10
US60/679,587 2005-05-10
US69315505P 2005-06-23 2005-06-23
US60/693,155 2005-06-23
PCT/US2006/017708 WO2006122021A1 (en) 2005-05-10 2006-05-08 Extrusion process for making compositions with poorly compressible therapeutic compounds

Publications (3)

Publication Number Publication Date
JP2008540540A JP2008540540A (ja) 2008-11-20
JP2008540540A5 true JP2008540540A5 (enExample) 2009-07-02
JP5400377B2 JP5400377B2 (ja) 2014-01-29

Family

ID=37022916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511233A Expired - Fee Related JP5400377B2 (ja) 2005-05-10 2006-05-08 圧縮性に乏しい治療用化合物を有する組成物の製造法

Country Status (16)

Country Link
US (2) US20100152299A1 (enExample)
EP (1) EP1881819A1 (enExample)
JP (1) JP5400377B2 (enExample)
KR (2) KR20130135403A (enExample)
CN (1) CN102552162A (enExample)
AU (2) AU2006244213B2 (enExample)
BR (1) BRPI0608609A2 (enExample)
CA (1) CA2607624A1 (enExample)
IL (1) IL186456A0 (enExample)
MA (1) MA29465B1 (enExample)
MX (1) MX2007014041A (enExample)
NO (1) NO20076298L (enExample)
NZ (2) NZ562304A (enExample)
RU (1) RU2405539C2 (enExample)
TN (1) TNSN07415A1 (enExample)
WO (1) WO2006122021A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
CN102014846A (zh) * 2008-04-30 2011-04-13 诺瓦提斯公司 制备药物组合物的连续方法
RU2491918C2 (ru) * 2008-07-03 2013-09-10 Новартис Аг Способ грануляции из расплава
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
PL2611425T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Odporna na ingerencję postać dawki zawierająca polimer anionowy
PL2736495T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
HRP20171458T1 (hr) 2011-07-29 2017-11-17 Grünenthal GmbH Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
LT2838512T (lt) 2012-04-18 2018-11-12 Grünenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
GB201218012D0 (en) * 2012-10-08 2012-11-21 Jagotec Ag Dosage forms
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6539274B2 (ja) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド 押出成形された即放性乱用抑止性丸剤
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
EP3285747A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles
CA2983648A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix
CA2983640A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant fixed dose combination providing fast release of two drugs from different particles
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
DE102018010063A1 (de) 2018-03-16 2019-09-19 Ludwig-Maximilians-Universität München Herstellung vesikulärer Phospholipid-Gele durch Schnecken-Extrusion
CN108888599B (zh) * 2018-07-26 2021-06-08 国药集团致君(深圳)制药有限公司 双氯芬酸钠缓释组合物及其制备方法
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
CN118234388A (zh) * 2021-11-16 2024-06-21 帝斯曼知识产权资产管理有限公司 可通过连续熔融造粒获得的高效力颗粒
WO2023088962A1 (en) * 2021-11-16 2023-05-25 Dsm Ip Assets B.V. Granule comprising encapsulated active ingredients
WO2023145871A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法
WO2023145869A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法
TW202412735A (zh) * 2022-08-31 2024-04-01 義大利商沙克米機械合作伊莫拉公司 製造固體藥劑的方法及裝置
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571046B1 (fr) * 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19504831A1 (de) * 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19509806A1 (de) * 1995-03-21 1996-09-26 Basf Ag Lagerstabile Arzneiformen
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
DE19934610A1 (de) * 1999-07-23 2001-01-25 Bayer Ag Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
DK1322158T3 (da) * 2000-10-02 2012-11-19 Usv Ltd Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
US20030021841A1 (en) * 2001-07-02 2003-01-30 Matharu Amol Singh Pharmaceutical composition
WO2003026637A2 (en) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Dosage form for treatment of diabetes mellitus
IN192180B (enExample) * 2001-09-28 2004-03-06 Ranbaxy Lab
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US20070098778A1 (en) * 2004-03-02 2007-05-03 Abeille Pharmaceuticals, Inc. Co-formulations or kits of bioactive agents
JOP20180109A1 (ar) * 2005-09-29 2019-01-30 Novartis Ag تركيبة جديدة
RU2430719C2 (ru) * 2005-11-09 2011-10-10 Новартис Аг Способ приготовления фармацевтических композиций с нестойким пластификатором

Similar Documents

Publication Publication Date Title
JP2008540540A5 (enExample)
RU2007145522A (ru) Экструзионный способ приготовления композиций, содержащих плохо прессующиеся лекарственные соединения
JP4041163B2 (ja) イソマルト含有ポリマー/活性物質溶融物の押出により得られる固形薬剤
RU2007145507A (ru) Фармацевтические композиции, содержащие иматиниб и замедлитель высвобождения
HRP20161262T1 (hr) Tablete ulipristal acetata
RU2014111723A (ru) Антиретровирусная комбинация
CA2591972C (en) Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
SK104397A3 (en) Solid active agent preparations
JP2006077018A5 (enExample)
US20110037185A1 (en) Continuous process for making pharmaceutical compositions
CN101584673A (zh) 一种左乙拉西坦片剂及其制备方法
RU2008147668A (ru) Способ получения фармацевтических композиций посредством прессования нагреваемыми роликами
TWI774159B (zh) 含有托格列淨(Tofogliflozin)之固體製劑及其製造方法
CN102176901A (zh) 生产可控释放口服剂型的方法
CN100563654C (zh) 一种地氯雷他定分散片及其制备方法
JP2012503665A5 (enExample)
RU2007145528A (ru) Фармацевтические композиции с модифицированным высвобождением фамцикловира
RU2010121824A (ru) Новая антиретровирусная комбинация
CN1302764C (zh) 一种妇科用药阴道凝胶片
KR101471240B1 (ko) 버스트 약물 방출 조성물
CN104069085A (zh) 一种阿司匹林肠溶缓释胶囊及其制备方法
CN101756977A (zh) 阿折地平的缓释制剂及其制备方法
CN1254240C (zh) 水飞蓟宾葡甲胺盐口腔崩解片及其制备工艺
RU2010135374A (ru) Экструзионный способ приготовления композиций, содержащих плохо прессующиеся лекарственные соединения
JP2004352633A (ja) 酸化マグネシウム錠剤